4rak
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
+ | |||
==Crystal structure of nuclear receptor subfamily 1, group h, member 2 (lxrb) complexed with partial agonist== | ==Crystal structure of nuclear receptor subfamily 1, group h, member 2 (lxrb) complexed with partial agonist== | ||
<StructureSection load='4rak' size='340' side='right' caption='[[4rak]], [[Resolution|resolution]] 2.04Å' scene=''> | <StructureSection load='4rak' size='340' side='right' caption='[[4rak]], [[Resolution|resolution]] 2.04Å' scene=''> | ||
Line 4: | Line 5: | ||
<table><tr><td colspan='2'>[[4rak]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4RAK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4RAK FirstGlance]. <br> | <table><tr><td colspan='2'>[[4rak]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4RAK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4RAK FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=652:2-{2-[2-(2-CHLOROPHENYL)PROPAN-2-YL]-1-[3-(METHYLSULFONYL)BIPHENYL-4-YL]-1H-IMIDAZOL-4-YL}PROPAN-2-OL'>652</scene>, <scene name='pdbligand=BU1:1,4-BUTANEDIOL'>BU1</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=652:2-{2-[2-(2-CHLOROPHENYL)PROPAN-2-YL]-1-[3-(METHYLSULFONYL)BIPHENYL-4-YL]-1H-IMIDAZOL-4-YL}PROPAN-2-OL'>652</scene>, <scene name='pdbligand=BU1:1,4-BUTANEDIOL'>BU1</scene></td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4rak FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4rak OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4rak RCSB], [http://www.ebi.ac.uk/pdbsum/4rak PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4rak FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4rak OCA], [http://pdbe.org/4rak PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4rak RCSB], [http://www.ebi.ac.uk/pdbsum/4rak PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4rak ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
Line 16: | Line 17: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 4rak" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> |
Revision as of 16:42, 11 August 2016
Crystal structure of nuclear receptor subfamily 1, group h, member 2 (lxrb) complexed with partial agonist
|
Categories: Nanao, M | Ligand binding domain | Lxr-b | Lxrb | Ner | Ner-i | Nhr | Nr1h2 | Nuclear hormone receptor | Rip15 | Rxr | Transcription-agonist complex | Unr